GlassScriptPhysician profile
Mark S Vrahas
NPI 1255315222
$29,507.82
in general payments reported to CMS, 2019-2025
7 companies · $2,680 in 2025
The $2,680 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $417 · 2021: $1,295 · 2023: $2,546 · 2024: $3,439 · 2025: $2,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,299 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000 · Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,299.34 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
| Food and Beverage | $365.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $18,231.83 | 2019 | |
| Synthes Gmbh | $9,299.34 | 2021-2025 | |
| Surgalign Spine Technologies, INC. | $1,407.92 | 2019-2021 | |
| Stryker Corporation | $224.38 | 2020-2023 | Axsos, Variax, Augment Injectable |
| Zimmer Biomet Holdings, INC. | $191.54 | 2024 | Ncb, Affixus, G7 |
| Smith+Nephew, INC. | $121.90 | 2019 | |
| Biom'Up Sa | $30.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Vrahas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.